Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.

Documenti analoghi

• Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy.
  di: Bahr, G M, et al.
  Pubblicazione: (1982)
• Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.
  di: Bahr, G M, et al.
  Pubblicazione: (1985)
• Specific absorption with monoclonal antibodies to muramyl dipeptide of the pyrogenic and somnogenic activities of rabbit monokine.
  di: Chedid, L, et al.
  Pubblicazione: (1984)
• Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).
  di: Richerson, H. B., et al.
  Pubblicazione: (1982)
• Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).
  di: Tanaka, A., et al.
  Pubblicazione: (1980)